Viemed Healthcare, Inc. (VMD)
USD 7.07
(0.0%)
USD 7.07
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 36.67 Million USD | 55.0% |
| 2022 | 24.02 Million USD | 3.3% |
| 2021 | 21.84 Million USD | -30.29% |
| 2020 | 30.53 Million USD | 118.48% |
| 2019 | 15.61 Million USD | -25.0% |
| 2018 | 13.89 Million USD | 26.16% |
| 2017 | 11.36 Million USD | 167.05% |
| 2016 | 1.8 Million USD | -43.77% |
| 2015 | 11.93 Million USD | 11.36% |
| 2014 | 9.87 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 9.6 Million USD | 20.67% |
| 2024 Q1 | 8.76 Million USD | -22.85% |
| 2023 Q2 | 8.34 Million USD | 25.39% |
| 2023 Q1 | 6.65 Million USD | 61.03% |
| 2023 Q4 | 11.88 Million USD | 10.81% |
| 2023 Q3 | 10.72 Million USD | 28.63% |
| 2023 FY | - USD | 55.0% |
| 2022 Q3 | 5.96 Million USD | 17.53% |
| 2022 Q4 | 4.13 Million USD | -30.76% |
| 2022 FY | - USD | 3.3% |
| 2022 Q1 | 5.96 Million USD | 15.08% |
| 2022 Q2 | 5.07 Million USD | -14.95% |
| 2021 Q4 | 5.18 Million USD | -17.18% |
| 2021 Q3 | 6.26 Million USD | 96.61% |
| 2021 Q2 | 3.18 Million USD | -22.18% |
| 2021 FY | - USD | -30.29% |
| 2021 Q1 | 4.09 Million USD | -27.2% |
| 2020 Q4 | 5.62 Million USD | -18.18% |
| 2020 FY | - USD | 118.48% |
| 2020 Q3 | 6.87 Million USD | 37.83% |
| 2020 Q2 | 4.98 Million USD | -10.16% |
| 2020 Q1 | 5.54 Million USD | 16.85% |
| 2019 Q1 | 6.09 Million USD | 2.39% |
| 2019 FY | - USD | -25.0% |
| 2019 Q4 | 4.74 Million USD | 78.94% |
| 2019 Q3 | 2.65 Million USD | -25.89% |
| 2019 Q2 | 3.58 Million USD | -41.22% |
| 2018 Q2 | 4.66 Million USD | -2.26% |
| 2018 Q3 | 5.44 Million USD | 16.88% |
| 2018 Q4 | 5.95 Million USD | 9.21% |
| 2018 FY | - USD | 26.16% |
| 2018 Q1 | 4.76 Million USD | 90.23% |
| 2017 FY | - USD | 167.05% |
| 2017 Q2 | 3.76 Million USD | -13.02% |
| 2017 Q1 | 4.32 Million USD | 92.14% |
| 2017 Q3 | 5.91 Million USD | 57.23% |
| 2017 Q4 | 2.5 Million USD | -57.62% |
| 2016 Q4 | 2.25 Million USD | 171.2% |
| 2016 Q3 | 830 Thousand USD | 0.0% |
| 2016 FY | - USD | -43.77% |
| 2015 FY | - USD | 11.36% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 371.943% |
| Cerus Corporation | -26.53 Million USD | 238.216% |
| OrthoPediatrics Corp. | -8.38 Million USD | 537.621% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 449.488% |
| Talis Biomedical Corporation | -66.04 Million USD | 155.533% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 319.952% |
| Inogen, Inc. | -45.67 Million USD | 180.293% |
| Spectral AI, Inc. | -12.26 Million USD | 399.111% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 176.902% |
| CVRx, Inc. | -38.73 Million USD | 194.697% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 1139.598% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 402.94% |
| Orthofix Medical Inc. | -86.98 Million USD | 142.165% |
| Venus Concept Inc. | -26.11 Million USD | 240.455% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 173.692% |
| Bioventus Inc. | -23.07 Million USD | 258.981% |
| BrainsWay Ltd. | -2.31 Million USD | 1687.062% |
| Envoy Medical, Inc. | -18.23 Million USD | 301.102% |
| electroCore, Inc. | -17.76 Million USD | 306.515% |
| IceCure Medical Ltd | -15.25 Million USD | 340.458% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 173.721% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 317.594% |
| MaxCyte, Inc. | -44.12 Million USD | 183.115% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 411.986% |
| Nexalin Technology, Inc. | -5.69 Million USD | 744.356% |
| PAVmed Inc | -75.74 Million USD | 148.424% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 168.226% |
| RxSight, Inc. | -41.03 Million USD | 189.375% |
| Sight Sciences, Inc. | -49.41 Million USD | 174.222% |
| SI-BONE, Inc. | -34.44 Million USD | 206.477% |
| TELA Bio, Inc. | -40.63 Million USD | 190.264% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 162.913% |
| Treace Medical Concepts, Inc. | -39 Million USD | 194.024% |
| LivaNova PLC | 39.01 Million USD | 5.995% |
| 908 Devices Inc. | -34.02 Million USD | 207.794% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 133.164% |
| Nemaura Medical Inc. | -7.28 Million USD | 603.317% |
| NeuroPace, Inc. | -22.83 Million USD | 260.625% |
| LENSAR, Inc. | -8.71 Million USD | 520.897% |
| Apyx Medical Corporation | -18.11 Million USD | 302.501% |
| Cutera, Inc. | -136.56 Million USD | 126.858% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 1185.118% |
| BioSig Technologies, Inc. | -28.15 Million USD | 230.287% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -1357.75% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 274.744% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 90.438% |
| Axonics, Inc. | 7.77 Million USD | -371.73% |
| Outset Medical, Inc. | -153.78 Million USD | 123.849% |
| IRIDEX Corporation | -7.44 Million USD | 592.441% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 137.389% |
| IRadimed Corporation | 20.8 Million USD | -76.326% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 554.937% |
| INVO Bioscience, Inc. | -6.88 Million USD | 633.094% |
| Telesis Bio, Inc. | -40.49 Million USD | 190.576% |
| Varex Imaging Corporation | 67.2 Million USD | 45.421% |
| Quipt Home Medical Corp. | 44.07 Million USD | 16.777% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 437.415% |
| Pulmonx Corporation | -55.09 Million USD | 166.574% |
| Dynatronics Corporation | -976 Thousand USD | 3857.859% |
| Modular Medical, Inc. | -17.1 Million USD | 314.448% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 353.207% |
| Semler Scientific, Inc. | 23.58 Million USD | -55.483% |
| InMode Ltd. | 196.28 Million USD | 81.314% |
| Bruker Corporation | 599 Million USD | 93.877% |
| Cytosorbents Corporation | -28.81 Million USD | 227.303% |
| DexCom, Inc. | 916.7 Million USD | 95.999% |
| Align Technology, Inc. | 799.03 Million USD | 95.41% |
| Viveve Medical, Inc. | -20.61 Million USD | 277.897% |
| ZimVie Inc. | 91.07 Million USD | 59.728% |
| Movano Inc. | -29.12 Million USD | 225.93% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 932.056% |
| Nexalin Technology, Inc. | -5.69 Million USD | 744.356% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 1139.598% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 118.842% |
| Profound Medical Corp. | -27.12 Million USD | 235.222% |
| Insulet Corporation | 323.6 Million USD | 88.666% |
| enVVeno Medical Corporation | -25.01 Million USD | 246.602% |
| Surmodics, Inc. | 1.18 Million USD | -2987.29% |
| iCAD, Inc. | -6.56 Million USD | 658.675% |
| Nuwellis, Inc. | -16.35 Million USD | 324.242% |
| Biotricity, Inc. | -8.82 Million USD | 515.45% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 137.865% |
| Aethlon Medical, Inc. | -11.84 Million USD | 409.534% |
| InspireMD, Inc. | -20.91 Million USD | 275.396% |
| PAVmed Inc. | -75.74 Million USD | 148.424% |
| BIOLASE, Inc. | -15.13 Million USD | 342.268% |
| Beyond Air, Inc. | -59.03 Million USD | 162.132% |
| FONAR Corporation | 28.25 Million USD | -29.823% |
| AxoGen, Inc. | -13.32 Million USD | 375.188% |
| Vivani Medical, Inc. | -26.6 Million USD | 237.842% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -49.452% |
| Inari Medical, Inc. | 7.11 Million USD | -415.633% |
| UFP Technologies, Inc. | 72.74 Million USD | 49.58% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 1183.264% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 695.793% |
| Tenon Medical, Inc. | -15.52 Million USD | 336.199% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 340.253% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 188.43% |
| AdaptHealth Corp. | -171.09 Million USD | 121.437% |
| Sintx Technologies, Inc. | -6.6 Million USD | 655.712% |
| NanoVibronix, Inc. | -3.43 Million USD | 1167.744% |
| Quanterix Corporation | -38.08 Million USD | 196.295% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 437.415% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -122156.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 113.227% |
| TransMedics Group, Inc. | -7.6 Million USD | 582.402% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 268.514% |
| NeuroMetrix, Inc. | -7.09 Million USD | 616.883% |
| Hyperfine, Inc. | -47.06 Million USD | 177.935% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 162.903% |
| Biomerica, Inc. | -5.99 Million USD | 711.997% |
| Bone Biologics Corporation | 479.57 Thousand USD | -7547.861% |
| AVITA Medical, Inc. | -39.56 Million USD | 192.694% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 499.839% |
| Silk Road Medical, Inc | -45.08 Million USD | 181.36% |